PDS Planning’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $733K | Sell |
10,493
-242
| -2% | -$16.9K | 0.05% | 170 |
|
|
2025
Q1 | $789K | Buy |
10,735
+1,561
| +17% | +$115K | 0.07% | 139 |
|
|
2024
Q4 | $601K | Sell |
9,174
-161
| -2% | -$10.5K | 0.05% | 163 |
|
|
2024
Q3 | $727K | Sell |
9,335
-2,048
| -18% | -$160K | 0.07% | 134 |
|
|
2024
Q2 | $888K | Buy |
11,383
+713
| +7% | +$55.6K | 0.09% | 96 |
|
|
2024
Q1 | $723K | Buy |
10,670
+281
| +3% | +$19K | 0.08% | 114 |
|
|
2023
Q4 | $700K | Sell |
10,389
-362
| -3% | -$24.4K | 0.08% | 103 |
|
|
2023
Q3 | $728K | Buy |
10,751
+345
| +3% | +$23.4K | 0.09% | 94 |
|
|
2023
Q2 | $745K | Buy |
10,406
+328
| +3% | +$23.5K | 0.1% | 95 |
|
|
2023
Q1 | $700K | Buy |
10,078
+2,692
| +36% | +$187K | 0.1% | 93 |
|
|
2022
Q4 | $501K | Buy |
7,386
+70
| +1% | +$4.75K | 0.08% | 95 |
|
|
2022
Q3 | $401K | Sell |
7,316
-50
| -0.7% | -$2.74K | 0.07% | 100 |
|
|
2022
Q2 | $487K | Buy |
7,366
+911
| +14% | +$60.2K | 0.09% | 94 |
|
|
2022
Q1 | $428K | Buy |
6,455
+905
| +16% | +$60K | 0.08% | 107 |
|
|
2021
Q4 | $323K | Sell |
5,550
-1,499
| -21% | -$87.2K | 0.06% | 129 |
|
|
2021
Q3 | $423K | Buy |
7,049
+1,345
| +24% | +$80.7K | 0.1% | 99 |
|
|
2021
Q2 | $342K | Buy |
5,704
+1,181
| +26% | +$70.8K | 0.08% | 116 |
|
|
2021
Q1 | $225K | Buy |
4,523
+280
| +7% | +$13.9K | 0.07% | 144 |
|
|
2020
Q4 | $212K | Buy |
4,243
+338
| +9% | +$16.9K | 0.07% | 141 |
|
|
2020
Q3 | $214K | Buy |
+3,905
| New | +$214K | 0.09% | 125 |
|